T2580000

Tropicamide

Name: Tropicamide
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

Sinónimos:

N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide, Ro 1-7683

Slide 1 of 1

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

En este momento no podemos mostrarle ni los precios ni la disponibilidad

Acerca de este artículo

Fórmula empírica (notación de Hill):

C₁₇H₂₀N₂O₂

Número CAS:

1508-75-4

Peso molecular:

284.35

NACRES:

NA.24

PubChem Substance ID:

329826715

UNSPSC Code:

41116107

MDL number:

MFCD00058580

Documentos clave

Ver Toda la documentación

Saltar a

Servicio técnico

¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.

Permítanos ayudarle

Nombre del producto

Tropicamide, European Pharmacopoeia (EP) Reference Standard

InChI

1S/C17H20N2O2/c1-2-19(12-14-8-10-18-11-9-14)17(21)16(13-20)15-6-4-3-5-7-15/h3-11,16,20H,2,12-13H2,1H3

SMILES string

CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2

InChI key

BGDKAVGWHJFAGW-UHFFFAOYSA-N

grade

pharmaceutical primary standard

API family

tropicamide

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

Gene Information

human ... CHRM3(1131)

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Analytical Reference Materials for Pharma QC

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 4

Este artículo	1699005	BP1047	Y0001316
T2580000 Tropicamide	USP 1699005 Tropicamide	BP1047 Tropicamide	Y0001316 Tropicamide for peak identification
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade pharmaceutical primary standard
manufacturer/tradename EDQM	manufacturer/tradename USP	manufacturer/tradename BP	manufacturer/tradename EDQM
format neat	format neat	format neat	format neat
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical pharmaceutical small molecule	application(s) pharmaceutical (small molecule)
API family tropicamide	API family tropicamide	API family tropicamide	API family tropicamide
storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C

Application

Tropicamide EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

pictograms

GHS07

signalword

Warning

hcodes

H302 + H312 + H332,H315,H317,H319,H335

pcodes

P261 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Ophthalmological consequences of cyanotic congenital heart disease: vascular parameters and nerve fibre layer.

Rachael Cordina et al.

Clinical & experimental ophthalmology, 43(2), 115-123 (2014-08-01)

This study investigated the long-term ophthalmological consequences of cyanotic congenital heart disease (CHD). Cross-sectional study, tertiary referral setting. Thirteen adults with cyanotic CHD (40 ± 4 years). Age- and sex-matched healthy controls underwent aspects of the protocol. Cyanosed subjects had a full

A novel murine model for keratoprosthesis.

Alja Crnej et al.

Investigative ophthalmology & visual science, 55(6), 3681-3685 (2014-05-17)

To establish a murine model for keratoprosthesis. A miniature keratoprosthesis (m-KPro) device was created consisting of a poly[methyl methacrylate] front part and a titanium back plate, designed after the Boston KPro, which is in widespread clinical use. BALB/c mice were

Retinal blood flow and vascular reactivity in chronic smokers.

Kalpana Rose et al.

Investigative ophthalmology & visual science, 55(7), 4266-4276 (2014-05-08)

The aim of this study was to investigate the impact of cigarette smoking in otherwise healthy young individuals on retinal blood flow (RBF) and vascular reactivity (RVR). An automated gas flow controller (RespirAct) was used to achieve normoxic hypercapnia in

Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis.

Anne E Powell et al.

American journal of physiology. Gastrointestinal and liver physiology, 307(1), G16-G23 (2014-05-17)

Individuals with familial adenomatous polyposis (FAP) harbor a germline mutation in adenomatous polyposis coli (APC). The major clinical manifestation is development of multiple colonic tumors at a young age due to stochastic loss of the remaining APC allele. Extracolonic features

Fundus autofluorescence (FAF) non-invasively identifies chorioretinal toxicity in a rat model of retinal pigment epithelium (RPE) damage.

David Sung Hyeon Baek et al.

Journal of pharmacological and toxicological methods, 71, 77-82 (2014-09-10)

Traditional methods of pre-clinical ocular toxicology require that multiple cohorts of animals be sacrificed over time for terminal histological analysis. By contrast, in vivo techniques capable of following the same cohort prospectively have the potential to be efficient and cost-saving.

Ver todos los artículos relacionados

Preguntas

Revisiones

Sin puntuación

Filtros activos

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico